Literature DB >> 6739221

Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA).

M D Murphy, P A Brunell, A W Lievens, Z M Shehab.   

Abstract

A measles epidemic in San Antonio, Texas provided a population of children who were immunized at less than or equal to 10 months of age and reimmunized at greater than or equal to 15 months of age. Of these children, 302 were evaluated for measles antibody by the sensitive enzyme-linked immunosorbent assay (ELISA), and their responses were compared with those of 300 children who had been immunized at the customary time (greater than or equal to 15 months) with a single immunization. There were only five seronegative findings in each group. The children immunized at the customary time did have significantly higher (P less than .001) antibody titers than the children immunized at less than or equal to 10 months and reimmunized at greater than or equal to 15 months. These results indicate that early immunization followed by reimmunization may be indicated when young infants are at significant risk of measles exposure. This approach should not create an increased number of serologically nonresponsive children when reimmunized at greater than or equal to 15 months.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6739221

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Immune response to 1 and 2 dose regimens of measles vaccine in Pakistani children.

Authors:  Hamidah Hussain; Dure Samin Akram; Subhash Chandir; Aamir J Khan; Ashraf Memon; Neal A Halsey
Journal:  Hum Vaccin Immunother       Date:  2013-08-08       Impact factor: 3.452

2.  Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.

Authors:  Sulachni Chandwani; Judy Beeler; Hong Li; Susette Audet; Betsy Smith; John Moye; David Nalin; Keith Krasinski
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

Review 3.  Two-dose measles vaccination schedules.

Authors:  S R Rosenthal; C J Clements
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

4.  Immunity to measles in young adults in Israel.

Authors:  Y Lerman; S Riskin-Mashiach; D Cohen; R Slepon; T Shohat; H Harari; M Wiener; Y L Danon
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

5.  Enzyme-linked immunosorbent assay for detection of antibody to human herpesvirus 6.

Authors:  K Chokephaibulkit; P A Brunell; V Vimal; C Long; K Schnabel; C B Hall
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

6.  Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles.

Authors:  A W Lievens; P A Brunell
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

7.  Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants.

Authors:  Hayley A Gans; Linda L Yasukawa; Cathryn Z Zhang; Rima Hanna Wakim; Mary Rinki; Ross Dehovitz; Ann M Arvin
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

8.  Anti-bovine antibody in human sera as a cause of nonspecificity in enzyme immunoassay.

Authors:  T Dise; P A Brunell
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

Review 9.  Measles control in the United States: problems of the past and challenges for the future.

Authors:  D L Wood; P A Brunell
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.